- Home
- Publications
- Publication Search
- Publication Details
Title
The known unknowns of HPV natural history
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 12, Pages 4593-4599
Publisher
American Society for Clinical Investigation
Online
2011-12-03
DOI
10.1172/jci57149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
- (2013) Jane J. Kim ANNALS OF INTERNAL MEDICINE
- Human Papillomavirus (HPV) 6, 11, 16, and 18 Seroprevalence Is Associated with Sexual Practice and Age: Results from the Multinational HPV Infection in Men Study (HIM Study)
- (2011) B. Lu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection
- (2011) Elizabeth Tronstein JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increases in Human Papillomavirus Detection During Early HIV Infection Among Women in Zimbabwe
- (2011) R. G. Nowak et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid Rise in Detection of Human Papillomavirus (HPV) Infection Soon After Incident HIV Infection Among South African Women
- (2011) C. Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Human Papillomavirus Testing in the Prevention of Cervical Cancer
- (2011) Mark Schiffman et al. JNCI-Journal of the National Cancer Institute
- Resident Memory T Cells (TRM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity
- (2011) Rahul Purwar et al. PLoS One
- Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
- (2011) Linda Ahdieh Grant et al. VACCINE
- Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression
- (2011) Gareth Adam Maglennon et al. VIROLOGY
- The natural history of human papillomavirus infections of the mucosal epithelia
- (2010) LOUISE T. CHOW et al. APMIS
- A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US
- (2010) Eileen F. Dunne et al. CANCER
- Incidence, Duration, and Reappearance of Type-Specific Cervical Human Papillomavirus Infections in Young Women
- (2010) R. P. Insinga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years
- (2010) P. Gonzalez et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
- (2010) H. Trottier et al. CANCER RESEARCH
- Human Papillomavirus Vaccines
- (2010) Suzanne M. Garland et al. DRUGS
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Sexual Behaviors, Condom Use, and Sexual Health of Americans Over 50: Implications for Sexual Health Promotion for Older Adults
- (2010) Vanessa Schick et al. Journal of Sexual Medicine
- Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
- (2010) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
- (2010) M. Safaeian et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
- (2010) Guglielmo Ronco et al. LANCET ONCOLOGY
- High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus–Infected Women
- (2010) Regan N. Theiler et al. OBSTETRICS AND GYNECOLOGY
- Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes
- (2010) J. T. Schiffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
- (2010) Nicolas Van de Velde et al. VACCINE
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study
- (2009) Stuart Collins et al. EUROPEAN JOURNAL OF CANCER
- HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
- (2009) Xavier Castellsagué et al. GYNECOLOGIC ONCOLOGY
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
- Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
- (2009) P. Naucler et al. JNCI-Journal of the National Cancer Institute
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Risk estimation for the next generation of prevention programmes for cervical cancer
- (2009) Hormuzd A Katki et al. LANCET ONCOLOGY
- HPV Screening for Cervical Cancer in Rural India
- (2009) Rengaswamy Sankaranarayanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Human Papillomavirus Seroepidemiology to Inform Vaccine Policy
- (2009) Mark Schiffman et al. SEXUALLY TRANSMITTED DISEASES
- Prevalence and Incidence of HPV Genital Infection in Women
- (2009) Christine Velicer et al. SEXUALLY TRANSMITTED DISEASES
- Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV
- (2009) Zainab A. Malik et al. VIRAL IMMUNOLOGY
- Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner
- (2008) Rachel L. Winer et al. JOURNAL OF INFECTIOUS DISEASES
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Modeling Cervical Cancer Prevention in Developed Countries
- (2008) Jane J. Kim et al. VACCINE
- Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
- (2008) F. Xavier Bosch et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation